· Published by Health Canada · Official notice
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| SIVEM PHARMACEUTICALS ULC | QUETIAPINE XR/50MG | DIN 02417359 | Tablet | QUETIAPINE (QUETIAPINE FUMARATE) 50 mg | M2213000, M2213001, M2215146, M2214004 |
| SIVEM PHARMACEUTICALS ULC | QUETIAPINE XR/150MG | DIN 02417367 | Tablet | QUETIAPINE (QUETIAPINE FUMARATE) 150 mg | M2214685, M2214686, M2214687 |
| SIVEM PHARMACEUTICALS ULC | QUETIAPINE XR/200MG | DIN 02417375 | Tablet | QUETIAPINE (QUETIAPINE FUMARATE) 200 mg | M2214012, M2214013, M2214014 |
| SIVEM PHARMACEUTICALS ULC | QUETIAPINE XR/300MG | DIN 02417383 | Tablet | QUETIAPINE (QUETIAPINE FUMARATE) 300 mg | M2214016, M2214017, M2214018 |
| SIVEM PHARMACEUTICALS ULC | QUETIAPINE XR/400MG | DIN 02417391 | Tablet | QUETIAPINE (QUETIAPINE FUMARATE) 400 mg | M2214020 |
Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).